R region sequences in the long terminal repeat of a murine retrovirus specifically increase expression of unspliced RNAs

Journal of Virology

Volumn 73, Issue 4, 1999, Pages 3477-3483

  Trubetskoy, Alla M ^a   Okenquist, Sharon A ^a,b   Lenz, Jack ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b REGENERON PHARMACEUTICALS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS MESSENGER RNA;

ARTICLE; GENE EXPRESSION; GENE EXPRESSION REGULATION; INTRON; LONG TERMINAL REPEAT; MESSENGER RNA SYNTHESIS; MURINE LEUKEMIA VIRUS; NONHUMAN; PRIORITY JOURNAL; REPORTER GENE; RNA PROCESSING; RNA STRUCTURE; STRUCTURE ANALYSIS; TRANSCRIPTION INITIATION; VIRUS GENOME; VIRUS TRANSCRIPTION;

EID: 0032978733     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.73.4.3477-3483.1999     Document Type: Article

References (74)

1. Trp primer is required for efficient initiation of reverse transcription. J. Virol. 66:2464-2472.
2. Amendt, B. A., S. B. Simpson, and C. M. Stoltzfus. 1995. Inhibition of RNA splicing at the Rous sarcoma virus src 3′ splice site is mediated by an interaction between a negative cis element and a chicken embryo fibroblast nuclear factor. J. Virol. 69:5068-5076.
3. Arrigo, S., and K. L. Beemon. 1988. Regulation of Rous sarcoma virus RNA splicing and stability. Mol. Cell. Biol. 8:4858-4867.
4. Berkhout, B. 1992. Structural features in TAR RNA of human and simian immunodeficiency viruses: a phylogenetic analysis. Nucleic Acids Res. 20: 27-31.
5. Berkhout, B., R. H. Silverman, and K. Jeang. 1989. Tat transactivates the human immunodeficiency virus through a nascent RNA target. Cell 59:273-282.
6. Bogerd, H. P., R. A. Fridell, S. Madore, and B. R. Cullen. 1995. Identification of a novel cellular cofactor for the Rev/Rex class of retroviral regulatory proteins. Cell 82:485-494.
7. Bray, M., S. Prasad, J. W. Dubay, E. Hunter, K. T. Jeang, D. Rekosh, and M. L. Hammarskjold. 1994. A small element from the Mason-Pfizer monkey virus genome makes human immunodeficiency virus type 1 expression and replication Rev-independent. Proc. Natl. Acad. Sci. USA 91:1256-1260.
8. Brinster, R. L., J. D. Allen, R. R. Behringer, R. E. Gelinas, and R. U. Palmiter. 1988. Introns increase transcriptional efficiency in transgenic mice. Proc. Natl. Acad. Sci. USA 85:836-840.
9. Brondyk, B. 1994. pCI and pSI mammalian expression vectors. Promega Notes 49:7-11.
10. Buchman, A. R., and P. Berg. 1988. Comparison of intron-dependent and intron-independent gene expression. Mol. Cell. Biol. 8:4395-4405.
11. Chang, D. D., and P. A. Sharp. 1989. Regulation by HIV Rev depends upon recognition of splice sites. Cell 59:789-795.
12. Choi, T., M. Huang, C. Gorman, and R. Jaenisch. 1991. A generic intron increases expression in transgenic mice. Mol. Cell. Biol. 11:3070-3074.
13. Cujec, T. P., H. Okamoto, K. Fujinaga, J. Meyer, H. Chamberlin, D. O. Morgan, and B. M. Peterlin. 1997. The HIV transactivator TAT binds to the CDK-activating kinase and activates the phosphorylation of the carboxyterminal domain of RNA polymerase II. Genes Dev. 11:2645-2657.
14. Cullen, B. R. 1990. The HIV-1 tat protein: an RNA sequence-specific processivity factor? Cell 63:655-657.
15. Cupelli, L., and J. Lenz. 1991. Transcriptional initiation and postinitiation effects of murine leukemia virus long terminal repeat R-region sequences. J. Virol. 65:6961-6968.
16. Cupelli, L., S. A. Okenquist, A. Trubetskoy, and J. Lenz. 1998. The secondary structure of the R region of a murine leukemia virus is important for stimulation of long terminal repeat-driven gene expression. J. Virol. 72: 7807-7814.
17. Cupelli, L. A., and J. Lenz. Unpublished results.
18. Daly, T. J., K. S. Cook, G. S. Gray, T. E. Maione, and J. R. Rusche. 1989. Specific binding of HIV-1 recombinant Rev protein to the Rev-responsive element in vitro. Nature 342:816-819.
19. Derse, D., and J. Casey. 1986. Two elements in the bovine leukemia virus long terminal repeat that regulate gene expression. Science 231:1437-1440.
20. Donello, J. E., A. A. Beeche, G. J. Smith, G. R. Lucero, and T. J. Hope. 1996. The hepatitis B virus posttranscriptional regulatory element is composed of two subelements. J. Virol. 70:4345-4351.
21. Donello, J. E., J. E. Loeb, and T. J. Hope. 1998. Woodchuck hepatitis virus contains a tripartite posttranscriptional regulatory element. J. Virol. 72: 5085-5092.
22. Ernst, R. K., M. Bray, D. Rekosh, and M. L. Hammarskjold. 1997. A structured retroviral RNA element that mediates nucleocytoplasmic export of intron-containing RNA. Mol. Cell. Biol. 17:135-144.
23. Fischer, U., J. Huber, W. C. Boelens, I. W. Mattaj, and R. Luhrmann. 1995 The HIV-1 Rev activation domain is a nuclear export signal that accesses an export pathway used by specific cellular RNAs. Cell 82:475-483.
24. Fridell, R. A., H. P. Bogerd, and B. R. Cullen. 1996. Nuclear export of late HIV-1 mRNAs occurs via a cellular protein export pathway. Proc. Natl. Acad. Sci. USA 93:4421-4424.
25. Fritz, C. C., and M. R. Green. 1996. HIV Rev uses a conserved cellular protein export pathway for the nucleocytoplasmic transport of viral RNAs. Curr. Biol. 6:848-854.
26. Fritz, C. C., M. L. Zapp, and M. R. Green. 1995. A human nucleoporin-like protein that specifically interacts with HIV Rev. Nature 376:530-533.
27. Fu, X. D., R. A. Katz, A. M. Skalka, and T. Maniatis. 1991. The role of branchpoint and 3′-exon sequences in the control of balanced splicing of avian retrovirus RNA. Genes Dev. 5:211-220.
28. Fu, X. Y., J. D. Colgan, and J. L. Manley. 1988. Multiple cis-acting sequence elements are required for efficient splicing of simian virus 40 small-t antigen pre-mRNA. Mol. Cell. Biol. 8:3582-3590.
29. Gontarek, R. R., M. T. McNally, and K. L. Beemon. 1993. Mutation of an RSV intronic element abolishes both U11/U12 snRNP binding and negative regulation of splicing. Genes Dev. 7:1926-1936.
30. Gorman, C. M., L. F. Moffat, and B. H. Howard. 1982. Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol. Cell. Biol. 2:1044-1051.
31. Hauber, J., and B. R. Cullen. 1988. Mutational analysis of the trans-activation-responsive region of the human immunodeficiency virus type 1 long terminal repeat. J. Virol. 62:673-679.
32. Hidaka, M., J. Inoue, M. Yoshida, and M. Seiki. 1988. Post-transcriptional regulator (rex) of HTLV-1 initiates expression of viral structural proteins but suppresses expression of regulatory proteins. EMBO J. 7:519-523.
33. Hope, T. J. 1997. Viral RNA export. Chem. Biol. 4:335-344.
34. Huang, M., and C. Gorman. 1990. Intervening sequences increase efficiency of RNA 3′ processing and accumulation of cytoplasmic RNA. Nucleic Acids Res. 18:937-947.
35. Huang, Z. M., and T. S. Yen. 1994. Hepatitis B virus RNA element that facilitates accumulation of surface gene transcripts in the cytoplasm. J. Virol. 68:3193-3199.
36. x-III) regulators are required for the expression and replication of human T-cell leukemia virus type I genes. Proc. Natl. Acad. Sci. USA 84:3653-3657.
37. Jones, K. A., P. A. Luciw, and N. Duchange. 1988. Structural arrangements of transcription control domains within the 5′-untranslated leader regions of the HIV-1 and HIV-2 promoters. Genes Dev. 2:1101-1114.
38. Kato, H., H. Sumimoto, P. Pognonec, C. H. Chen, C. A. Rosen, and R. G. Roeder. 1992. HIV-1 Tat acts as a processivity factor in vitro in conjunction with cellular elongation factors. Genes Dev. 6:655-666.
39. Katz, R. A., and A. M. Skalka. 1990. Control of retroviral RNA splicing through maintenance of suboptimal processing signals. Mol. Cell. Biol. 10: 696-704.
40. Kiss-Toth, E., and I. Unk. 1994. A downstream regulatory element activates the bovine leukemia virus promoter. Biochem. Biophys. Res. Commun. 202:1553-1561.
41. Laspia, M. F., A. P. Rice, and M. B. Mathews. 1989. HIV-1 tat protein increases transcriptional initiation and stabilizes elongation. Cell 59:283-292.
42. Laspia, M. F., A. P. Rice, and M. B. Mathews. 1990. Synergy between HIV-1 Tat and adenovirus E1A is principally due to stabilization of transcriptional elongation. Genes Dev 4:2397-2408.
43. Legrain, P., and M. Rosbash. 1989. Some cis- and trans-acting mutants for splicing target pre-mRNA to the cytoplasm. Cell 57:573-583.
44. Lobel, L. I., and S. P. Goff. 1985. Reverse transcription of retroviral genomes: mutations in the terminal repeat sequences. J. Virol. 53:447-455.
45. Malim, M. H., and B. R. Cullen. 1993. Rev and the fate of pre-mRNA in the nucleus: implications for the regulation of RNA processing in eukaryotes. Mol. Cell. Biol. 13:6180-6189.
46. Malim, M. H., J. Hauber, S. Le, J. Maizel, and B. R. Cullen. 1989. The HIV-1 rev trans-activator acts through a structured target sequence to activate nuclear export of unspliced viral mRNA. Nature 338:254-257.
47. Marciniak, R. A., and P. A. Sharp. 1991. HIV-1 Tat protein promotes formation of more-processive elongation complexes. EMBO J. 10:4189-4196.
48. McNally, M. T., and K. L. Beemon. 1992. Intronic sequences and 3′ splice sites control Rous sarcoma virus RNA splicing. J. Virol. 66:6-11.
49. Miller, J. T., and C. M. Stoltzfus. 1992. Two distant upstream regions containing cis-acting signals regulating splicing facilitate 3′-end processing of avian sarcoma virus RNA. J. Virol. 66:4242-4251.
50. Montagne, J., and P. Jalinot. 1995. Characterization of a transcriptional attenuator within the 5′ R region of the human T cell leukemia virus type 1. AIDS Res. Hum. Retroviruses 11:1123-1129.
51. Ogert, R. A., and K. L. Beemon. 1998. Mutational analysis of the Rous sarcoma virus DR posttranscriptional control element. J. Virol. 72:3407-3411.
52. Ogert, R. A., L. H. Lee, and K. L. Beemon. 1996. Avian retroviral RNA element promotes unspliced RNA accumulation in the cytoplasm. 1. Virol. 70:3834-3843.
53. Ohtani, K., M. Nakamura, S. Saito, T. Noda, Y. Ito, K. Sugamura, and Y. Hinuma. 1987. Identification of two distinct elements in the long terminal repeat of HTLV-I responsible for maximum gene expression. EMBO J. 6:389-395.
54. Oshima, M., T. Odawara, K. Hanaki, H. Igarashi, and H. Yoshikura. 1998. cis elements required for high-level expression of unspliced gag-containing message in Moloney murine leukemia virus. J. Virol. 72:6414-6420.
55. Pasquinelli, A. E., R. K. Ernst, E. Lund, C. Grimm, M. L. Zapp, D. Rekosh, M. L. Hammarskjold, and J. E. Dahlberg. 1997. The constitutive transport element (CTE) of Mason-Pfizer monkey virus (MPMV) accesses a cellular mRNA export pathway. EMBO J. 16:7500-7510.
56. Pierce, J., B. E. Fee, M. G. Toohey, and D. O. Peterson. 1993. A mouse mammary tumor virus promoter element near the transcription initiation site. J. Virol. 67:415-424.
57. Poole, T. L., and A. Stevens. 1997. Structural modifications of RNA influence the 5′ exoribonucleolytic hydrolysis by XRN1 and HKE1 of Saccharomyces cerevisiae. Biochem. Biophys. Res. Commun. 235:799-805.
58. Ridgway, A. A. G., H.-J. Kung, and D. J. Fujita. 1989. Transient expression analysis of the reticuloendotheliosis virus long terminal repeat element. Nucleic Acids Res. 17:3199-3215.
59. Rosen, C. A., J. Sodroski, and W. A. Haseltine. 1985. The location of cis-acting regulatory sequences in the human T cell lymphotropic virus type III (HTLV-III/LAV) long terminal repeat. Cell 41:813-823.
60. Sarabrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
61. Schwer, B., X. Mao, and S. Shuman. 1998. Accelerated mRNA decay in conditional mutants of yeast mRNA capping enzyme. Nucleic Acids Res. 26:2050-2057.
62. Selby, M. J., and B. M. Peterlin. 1990. Trans-activation by HIV-1 Tat via a heterologous RNA binding protein. Cell 62:769-776.
63. Senapathy, P., M. B. Shapiro, and N. L. Harris. 1990. Splice junctions, branch point sites, and exons: sequence statistics, identification, and application to genome project. Methods Enzymol. 183:252-278.
64. Southgate, C., M. L. Zapp, and M. R. Green. 1990. Activation of transcription by HIV-1 Tat protein tethered to nascent RNA through another protein. Nature 345:640-642.
65. Stutz, F., E. Izaurralde, I. W. Mattaj, and M. Rosbash. 1996. A role for nucleoporin FG repeat domains in export of human immunodeficiency virus type 1 Rev protein and RNA from the nucleus. Mol. Cell. Biol. 16:7144-7150.
66. Stutz, F., M. Neville, and M. Rosbash. 1995. Identification of a novel nuclear pore-associated protein as a functional target of the HIV-1 Rev protein in yeast. Cell 82:495-506.
67. Tabernero, C., A. S. Zolotukhin, A. Valentin, G. N. Pavlakis, and B. K. Felber. 1996. The posttranscriptional control element of the simian retrovirus type 1 forms an extensive RNA secondary structure necessary for its function. J. Virol. 70:5998-6011.
68. Trubetskoy, A., S. Okenquist, and J. Lenz. Unpublished results.
69. Wei, P., M. E. Garber, S. M. Fang, W. H. Fischer, and K. A. Jones. 1998. A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA. Cell 92:451-462.
70. Yang, X., M. O. Gold, D. N. Tang, D. E. Lewis, E. Aguilar-Cordova, A. P. Rice, and C. H. Herrmann. 1997. TAK, an HIV Tat-associated kinase, is a member of the cyclin-dependent family of protein kinase and is induced by activation of peripheral blood lymphocytes and differentiation of promonocytic cell lines. Proc. Natl. Acad. Sci. USA 94:12331-12336.
71. Zapp, M. L., and M. R. Green. 1989. Sequence-specific RNA binding by the HIV-1 Rev protein. Nature 342:816-819.
72. Zhang, L., and C. M. Stoltzfus. 1998. A suboptimal src 3′ splice site is necessary for efficient replication of Rous sarcoma virus. Virology 206:1099-1107.
73. Zhuang, Y., H. Leung, and A. M. Weiner. 1987. The natural 5′ splice site of simian virus 40 large T antigen can be improved by increasing the base complementarity to U1 RNA. Mol. Cell. Biol. 7:3018-3020.
74. Zolotukhin, A. S., A. Valentin, G. N. Pavlakis, and B. K. Felber. 1994. Continuous propagation of RRE(-) and Rev(-)RRE(-) human immunodeficiency virus type 1 molecular clones containing a cis-acting element of simian retrovirus type 1 in human peripheral blood lymphocytes. J. Virol. 68:7944-7952.